Form4insider filings, from the source

SEC Form 4 · accession 0001562180-16-003663

WEST PHARMACEUTICAL SERVICES INC · WST

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Karen Flynn
Officer — Sr VP & Chief Commercial Offic
Period of report
Dec 2, 2016
Accepted (ET)
Dec 5, 2016 · 9:08 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000105770

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockDec 2, 2016A9$80.57A1,206INon-Qualified Deferred Compensation Plan
Common Stockholding———13,580D
Common Stockholding———251IBy Savings Plan

Table II — derivative securities

No Table II lines on this filing.